144 related articles for article (PubMed ID: 30545740)
1. Estimating the Cost of Illness of Prostate Cancer in Iran.
Mojahedian MM; Toroski M; Keshavarz K; Aghili M; Zeyghami S; Nikfar S
Clin Ther; 2019 Jan; 41(1):50-58. PubMed ID: 30545740
[TBL] [Abstract][Full Text] [Related]
2. Economic Burden of Gastric Cancer: A Case of Iran.
Eghdami A; Ostovar R; Jafari A; Palmer AJ; Bordbar N; Ravangard R
Cancer Control; 2019; 26(1):1073274819837185. PubMed ID: 30924358
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Direct Costs of Gastric Cancer Treatment in Iran - Case Study in Kerman City in 2015.
Izadi A; Sirizi MJ; Esmaeelpour S; Barouni M
Asian Pac J Cancer Prev; 2016; 17(6):3007-13. PubMed ID: 27356726
[TBL] [Abstract][Full Text] [Related]
5. Costs in different states of prostate cancer.
Torvinen S; Färkkilä N; Roine RP; Sintonen H; Saarto T; Taari K
Acta Oncol; 2016; 55(1):30-7. PubMed ID: 25833414
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):987-92. PubMed ID: 10763396
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran.
Ghaffari Darab M; Keshavarz K; Sadeghi E; Shahmohamadi J; Kavosi Z
BMC Health Serv Res; 2021 Feb; 21(1):132. PubMed ID: 33573650
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of prostate cancer - a Swedish prevalence-based register study.
Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
[TBL] [Abstract][Full Text] [Related]
9. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
[TBL] [Abstract][Full Text] [Related]
10. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
Reinhold T; Dornquast C; Börgermann C; Weißbach L
Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of medication-overuse headache in Iran: direct and indirect costs.
Togha M; Nadjafi-Semnani F; Martami F; Mohammadshirazi Z; Vahidpour N; Akbari-Sari A; Daroudi R
Neurol Sci; 2021 May; 42(5):1869-1877. PubMed ID: 32948933
[TBL] [Abstract][Full Text] [Related]
12. Economic Burden of Colorectal Cancer: A Case of Fars, Iran.
Jafari A; Alamdarloo PM; Dehghani M; Bastani P; Ravangard R
Cancer Control; 2021; 28():10732748211009952. PubMed ID: 33882706
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs associated with prostate cancer: estimates from a population-based study.
Krahn MD; Zagorski B; Laporte A; Alibhai SM; Bremner KE; Tomlinson G; Warde P; Naglie G
BJU Int; 2010 Feb; 105(3):338-46. PubMed ID: 19594734
[TBL] [Abstract][Full Text] [Related]
14. The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
Sherman EJ; Pfister DG; Ruchlin HS; Rubin DM; Radzyner MH; Kelleher GH; Slovin SF; Kelly WK; Scher HI
Cancer; 2001 Feb; 91(4):841-53. PubMed ID: 11241254
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect costs of nonfatal road traffic injuries in Iran: A population-based study.
Karimi H; Soleyman-Jahi S; Hafezi-Nejad N; Rahimi-Movaghar A; Amin-Esmaeili M; Sharifi V; Hajebi A; Saadat S; Akbari Sari A; Rahimi-Movaghar V
Traffic Inj Prev; 2017 May; 18(4):393-397. PubMed ID: 27574963
[TBL] [Abstract][Full Text] [Related]
16. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the prostate: an expensive way to die.
Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of major depressive disorder: a case study in Southern Iran.
Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
[TBL] [Abstract][Full Text] [Related]
19. Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.
Gordon LG; Tuffaha HW; James R; Keller AT; Lowe A; Scuffham PA; Gardiner RA
Urol Oncol; 2018 Mar; 36(3):91.e7-91.e15. PubMed ID: 29169847
[TBL] [Abstract][Full Text] [Related]
20. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
